Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study-Reference-Cited by-同舟云学术

Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study

Published:2020-08-28 Issue:7 Volume:66 Page:2427-2438
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Hyun Hye Kyung,Cho Eun Ju,Park Soo Young,Hong Young Mi,Kim Soon Sun,Kim Hwi Young,Heo Nae-Yun,Park Jung Gil,Sinn Dong Hyun,Kang Wonseok,Jeong Song Won,Song Myeong Jun,Park Hana,Lee Danbi,Lee Yong Sun,Cho Sung Bum,An Chan Sik,Rhee Hyung Jin,Lee Hyun Woong,Kim Beom Kyung,Park Jun Yong,Kim Do Young,Ahn Sang Hoon,Han Kwang-Hyub,Lee Jeong-Hoon,Yu Su Jong,Kim Yoon Jun,Yoon Jung-Hwan,Tak Won Young,Kweon Young Oh,Yoon Ki Tae,Cho Mong,Cheong Jae Youn,Park Seung Ha,Kim Seung Up^ORCID,

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-020-06533-7.pdf

Reference30 articles.

1. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975–982. https://doi.org/10.1056/NEJMoa020047.

2. von Wagner M, Huber M, Berg T, et al. Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C. Gastroenterology. 2005;129:522–527. https://doi.org/10.1016/j.gastro.2005.05.008.

3. Alazard-Dany N, Denolly S, Boson B, et al. Overview of HCV life cycle with a special focus on current and possible future antiviral targets. Viruses. 2019. https://doi.org/10.3390/v11010030.

4. Kohli A, Shaffer A, Sherman A, et al. Treatment of hepatitis C: a systematic review. JAMA. 2014;312:631–640. https://doi.org/10.1001/jama.2014.7085.

5. Kimer N, Dahl EK, Gluud LL, et al. Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2012. https://doi.org/10.1136/bmjopen-2012-001313.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seven gene signature explores the impact of DAAs on the appearance of hepatocellular carcinoma in HCV infected patients;Heliyon;2022-08

2. Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea;Journal of Gastroenterology and Hepatology;2021-04-12